8-K: Visium Secures $100K Funding via Convertible Note

Sentiment:

Debt and Equity Financing


Visium Technologies, Inc. secured $100,000 in new funding through a convertible promissory note and issued 750,000 commitment shares to Labrys Fund II, L.P.

Capital raiseVisium Technologies, Inc. secured $100,000 in cash from Labrys Fund II, L.P.The capital raise is structured as a convertible promissory note with a principal amount of $120,000, including a $20,000 original issue discount.The company also issued 750,000 shares of common stock as commitment shares to the investor.The note carries a 15% annual interest rate and matures in 12 months.Conversion of the note into common stock is triggered only upon an event of default, at a price equal to 65% of the lowest closing bid price over the preceding ten trading days.The proceeds are earmarked for business development and general working capital.
Worse than expectedThe $20,000 original issue discount on a $100,000 cash infusion means the company immediately owes $120,000 for $100,000 received, effectively increasing the cost of capital.The 15% annual interest rate is very high, indicating a costly debt burden.The issuance of 750,000 commitment shares and the highly dilutive conversion terms (65% of the lowest closing bid price) suggest significant future dilution for existing shareholders.The 150% default penalty is an extremely punitive term, exposing the company to substantial financial risk if it breaches any of the numerous covenants.

Summary

  • Visium Technologies, Inc. entered into a Securities Purchase Agreement with Labrys Fund II, L.P. on August 13, 2025.
  • The company issued a Convertible Promissory Note with a principal amount of $120,000 for a purchase price of $100,000, reflecting a $20,000 original issue discount.
  • An additional 750,000 shares of common stock were issued to the buyer as commitment shares.
  • The Note bears interest at 15% per annum and matures in twelve months from the issue date (August 13, 2026).
  • Conversion into common stock is only permitted upon an event of default, at a conversion price equal to 65% of the lowest closing bid price during the ten trading days immediately preceding the conversion date.
  • The beneficial ownership limitation for conversion is 4.99%, which can be increased to 9.99% upon 61 days prior written notice.
  • Proceeds from the financing are designated for business development and general working capital.
  • Monthly amortization payments of $10,831 are scheduled from September 14, 2025, with the final payment on August 13, 2026, covering all remaining outstanding amounts.

Sentiment

Score: 2

Explanation: The financing terms are highly unfavorable to the company and existing shareholders, characterized by a significant discount, high interest rate, substantial dilution, and punitive default provisions. While capital was raised, the cost and associated risks are very high.

Positives

  • Secured $100,000 in new capital for business development and general working capital.
  • The funding is explicitly restricted from being used for certain types of debt repayment or loans to affiliates, which could be seen as a positive for corporate governance.

Negatives

  • The $100,000 purchase price for a $120,000 principal note implies a significant original issue discount of $20,000 (20% of the cash received).
  • The 15% annual interest rate is high, indicating a costly financing arrangement.
  • The issuance of 750,000 commitment shares and potential future conversion shares (at 65% of lowest bid price) poses significant dilution risk to existing shareholders.
  • Conversion rights are triggered only upon an event of default, which could incentivize the lender to seek default conditions.
  • Upon an event of default, the note becomes immediately due and payable at 150% of the outstanding principal plus accrued interest, representing a substantial penalty.
  • The "Most Favored Nation" clause for future financings could limit the company's flexibility in securing more favorable terms from other investors in the future.
  • Strict penalties for non-compliance, including liquidated damages for failure to offer participation in future placements ($10,000 minimum or 10% of principal) or for disclosing material non-public information without an 8-K ($3,000 per day).

Risks

  • Dilution Risk: Significant potential dilution from the 750,000 commitment shares and future conversion of the note, especially given the conversion price is tied to a discount on the lowest closing bid price.
  • High Cost of Capital: The 15% interest rate and $20,000 original issue discount make this a very expensive form of financing.
  • Default Risk: Numerous events can trigger a default, leading to immediate repayment at a 150% premium.
  • Liquidity Risk: Failure to maintain listing or quotation on a Principal Market is an Event of Default.
  • Operational Restrictions: Covenants restrict changing business nature or selling material assets outside ordinary course without lender consent.
  • Future Financing Constraints: The "Most Favored Nation" clause may hinder the company's ability to secure more favorable financing terms from other parties in the future without extending those terms to the current noteholder.
  • Regulatory Compliance Risk: Failure to comply with 1934 Act reporting requirements or inability to obtain Rule 144 legal opinions are events of default.
  • Litigation Risk: All claims are subject to binding arbitration in Massachusetts, with a waiver of jury trial.

Future Outlook

The company intends to use the proceeds from this financing for business development and general working capital, aiming to support its ongoing operations and growth initiatives.

Management Comments

  • The company acknowledges and understands the potentially dilutive effect of the Conversion Shares upon the conversion of the Note and Commitment Shares to the Common Stock.
  • The company further acknowledges that its obligation to issue, upon conversion of the Note, the Conversion Shares, as well as the Commitment Shares, are absolute and unconditional regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

Industry Context

This financing arrangement is typical for smaller, publicly traded companies, particularly those in the technology sector, that may have limited access to traditional bank lending or larger equity raises. Convertible notes with high interest rates and significant discounts are often utilized by companies seeking quick capital infusions but come with substantial dilution and default risks. The 'Most Favored Nation' clause and strict default provisions are common in such high-risk, high-reward financing structures from specialized funds like Labrys Fund II, L.P.

Comparison to Industry Standards

  • The 15% interest rate and 20% original issue discount are significantly higher than typical corporate debt for established companies, reflecting the higher risk associated with smaller, potentially less liquid issuers. For example, investment-grade corporate bonds might yield 3-6%, while high-yield (junk) bonds could range from 7-12%. This note's terms are indicative of distressed or very early-stage financing.
  • The conversion price being 65% of the lowest closing bid price over 10 days is a highly dilutive feature, often seen in toxic debt or death spiral financings, as it incentivizes the lender to drive down the stock price to maximize conversion shares. This contrasts sharply with fixed conversion prices or conversion prices based on average market prices without such a deep discount.
  • The 150% default penalty is a severe term, exceeding standard default penalties which typically involve acceleration of principal and accrued interest, sometimes with a modest premium (e.g., 10-20%).
  • The "Most Favored Nation" clause is a common protective measure for lenders in such financings, ensuring they receive terms as good as any subsequent investor, but it can constrain the company's ability to raise future capital on better terms.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Financing CovenantsThe company is now subject to strict covenants, including restrictions on changing the nature of its business, selling material assets outside the ordinary course, and making certain distributions on capital stock without the lender's consent.2025-08-13These covenants limit the company's operational and financial flexibility, potentially hindering strategic initiatives or asset dispositions without lender approval.
Information Disclosure PolicyThe company is obligated not to provide material non-public information to the lender without consent and confidentiality, or without simultaneously filing a Form 8-K, with a $3,000 per day penalty for non-compliance.2025-08-13This reinforces regulatory compliance but imposes a significant financial penalty for any oversight in information disclosure, increasing operational risk.
Future Financing Participation RightsThe lender has a "Most Favored Nation" right, entitling them to participate in future equity or debt offerings and receive any more favorable terms offered to other investors.2025-08-13This could constrain the company's ability to negotiate better terms with new investors in the future, as any superior terms would automatically extend to the current lender, potentially deterring new investment.
Dispute Resolution MechanismAll claims and disputes arising from the transaction documents or relationship are subject to binding arbitration in Massachusetts, with a waiver of jury trial.2025-08-13This streamlines dispute resolution but limits the company's legal avenues and rights in potential conflicts with the lender.

Stakeholder Impact

  • Shareholders: Significant negative impact due to immediate and potential future dilution from commitment shares and convertible note terms (65% discount on lowest bid price). The high interest rate and punitive default terms also increase financial risk, potentially eroding shareholder value.
  • Creditors: The new convertible note adds to the company's debt burden. The high interest rate and OID suggest a higher risk profile for the company, which could affect its ability to secure future debt on favorable terms.
  • Management/Employees: The strict covenants and financial penalties for non-compliance add pressure on management to adhere to the terms, potentially impacting operational flexibility.

Next Steps

  • Make monthly amortization payments starting September 14, 2025.
  • Maintain compliance with all covenants in the Securities Purchase Agreement and Convertible Promissory Note, including reporting requirements, listing standards, and restrictions on business activities.
  • Manage potential dilution from commitment shares and future conversions.
  • Ensure sufficient shares are reserved for potential conversions.

Key Dates

DateDescription
2025-08-13Date of earliest event reported; Issue Date of Convertible Promissory Note and Securities Purchase Agreement.
2025-09-14First scheduled amortization payment date ($10,831.00).
2025-10-15Second scheduled amortization payment date ($10,831.00).
2025-11-14Third scheduled amortization payment date ($10,831.00).
2025-12-15Fourth scheduled amortization payment date ($10,831.00).
2026-01-14Fifth scheduled amortization payment date ($10,831.00).
2026-02-13Sixth scheduled amortization payment date ($10,831.00).
2026-03-13Seventh scheduled amortization payment date ($10,831.00).
2026-04-14Eighth scheduled amortization payment date ($10,831.00).
2026-05-14Ninth scheduled amortization payment date ($10,831.00).
2026-06-15Tenth scheduled amortization payment date ($10,831.00).
2026-07-14Eleventh scheduled amortization payment date ($10,831.00).
2026-08-13Maturity Date of the Convertible Promissory Note; Final scheduled amortization payment date (all remaining outstanding amounts).
2025-08-19Date the Form 8-K was signed by Mark Lucky, CEO.

Recommendation

strong sell

The terms of this financing are highly detrimental to existing shareholders. The significant original issue discount, high interest rate, and particularly the deeply dilutive conversion terms (65% of the lowest bid price) suggest a 'toxic' financing structure that could lead to substantial share price erosion. The punitive 150% default penalty and numerous events of default create significant financial instability and risk of further value destruction. This type of financing often precedes severe dilution and financial distress, making the stock a strong sell for investors.

Keywords

Convertible Note, Securities Purchase Agreement, Debt Financing, Equity Dilution, SEC Filing, 8-K, Corporate Finance, High Interest Debt, Small Cap Funding, Visium Technologies

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.